section name header

Information

AHFS Class:

8:12.16.12 Penicillinase-resistant Penicillins


Generic Name

Products

Nafcillin sodium is available as a powder in vials containing the equivalent of 1 or 2 g of nafcillin and a 10-g pharmacy bulk package.2801; 2808 The formulation contains sodium citrate 40 mg per gram of nafcillin as buffer.2801 Reconstitute the 1-g vial with 3.4 mL and the 2-g vial with 6.6 mL of sterile water for injection, sodium chloride 0.9%, or bacteriostatic water for injection containing parabens or benzyl alcohol to yield a solution containing nafcillin 250 mg/mL.2801 The final volumes of the 1- and 2-g vials are 4 and 8 mL, respectively.2801

The 10-g pharmacy bulk package should be reconstituted with 93 mL of sterile water for injection or sodium chloride 0.9% to yield a 100-mg/mL solution.2808

Nafcillin sodium is also available as a frozen premixed infusion solution in single-dose Galaxy plastic containers containing the equivalent of 1 or 2 g of nafcillin in 50- or 100-mL, respectively, with dextrose to adjust osmolality and hydrochloric acid and/or sodium hydroxide to adjust the pH.2809 The premixed solution also contains sodium citrate approximately 90 mg for each gram of nafcillin as buffer.2809

pH

The pH of the reconstituted solution and frozen premixed solution is 6 to 8.5.2801; 2809

Osmolality

The osmolality of nafcillin sodium 250 mg/mL in sterile water for injection was 709 mOsm/kg by freezing-point depression and 665 mOsm/kg by vapor pressure.1071

The frozen premixed solution is iso-osmotic.2809

The osmolality of nafcillin sodium (Wyeth) 40 mg/mL was determined to be 403 mOsm/kg in dextrose 5% and 402 mOsm/kg in sodium chloride 0.9%.1375

The osmolality of nafcillin sodium was calculated for the following dilutions1054:

Osmolality (mOsm/kg)
Nafcillin in Diluent50 mL100 mL
2 g in Dextrose 5%399334
2 g in Sodium chloride 0.9%425361
3 g in Dextrose 5%458371
3 g in Sodium chloride 0.9%485398

The following maximum nafcillin sodium concentrations were recommended to achieve osmolalities suitable for peripheral infusion in fluid-restricted patients1180:

DiluentMaximum
Concentration
(mg/mL)
Osmolality
(mOsm/kg)
Dextrose 5%71491
Sodium chloride 0.9%64470
Sterile water for injection128319

Sodium Content

Each gram of nafcillin sodium with sodium citrate buffer contains 66 mg (2.9 mEq) of sodium.27; 2801

The frozen premixed solution contains 76.6 mg (3.33 mEq) of sodium per gram of nafcillin.2809(2809)

Administration

Nafcillin sodium is administered by intramuscular (deep intragluteal) injection, direct intravenous injection, or intermittent intravenous infusion.2801 For direct intravenous injection, the reconstituted solution should be diluted with 15 to 30 mL of sterile water for injection or sodium chloride injection and administered over 5 to 10 minutes.2801 For intermittent intravenous infusion, the dose should be diluted in a compatible infusion solution and administered over 30 to 60 minutes.2801

Premixed infusion solutions and diluted solutions prepared from pharmacy bulk packages are intended for intravenous infusion only.2808; 2809 The intravenous infusion should be administered over 30 to 60 minutes.2808; 2809

Stability

Nafcillin sodium is a white to yellowish-white powder.2801; 2808 Intact vials and pharmacy bulk packages should be stored at controlled room temperature.2801; 2808

Solutions reconstituted with sterile water for injection or sodium chloride 0.9% are stated to be stable for 24 hours at room temperature (25°C) or 7 days under refrigeration (5°C) at concentrations of 10 to 200 mg/mL, or 90 days frozen at -15°C at a concentration of 250 mg/mL.2801 Reconstituted solutions prepared from pharmacy bulk packages should be further diluted for infusion within 4 hours after initial entry into the vial.2808 Unused portions of pharmacy bulk packages should be discarded after 4 hours of initial entry.2808

Solutions further diluted for infusion are stated to be stable for 24 hours at room temperature or 7 days under refrigeration for the following diluents and concentrations: Sterile water for injection or sodium chloride 0.9% at 10 to 200 mg/mL; dextrose 5% or dextrose 5% in sodium chloride 0.45% at 2 to 30 mg/mL; sodium lactate 1by6 M at 30 mg/mL; and Ringer's injection, lactated at 10 to 30 mg/mL.2801; 2808

Commercially-available frozen premixed solutions in single-dose Galaxy containers should be stored at -20°C and thawed at room temperature (25°C) or under refrigeration (5°C).2809 Do not force thaw by immersion in water baths or microwaving.2809 Thawed solutions are stable for 72 hours at room temperature or 21 days under refrigeration.2809 Thawed solutions should not be refrozen.2809 The manufacturer states that precipitation may occur in the frozen solution which will dissolve with little or no agitation upon reaching room temperature.2809 The container should be agitated upon reaching room temperature.2809 Discard the solution if it is cloudy or precipitate is present.2809

pH Effects

The stability of nafcillin sodium is pH dependent, with a maximum stability at pH 6 and a preferred range of pH 5 to 8. Drug decomposition is increased as pH values vary from this range. Additives that may result in a final pH of above 8 or below 5 should not be mixed with nafcillin sodium.27

Freezing Solutions

Reconstituted solutions at a concentration of 250 mg/mL in sterile water for injection or sodium chloride 0.9% are stated to be stable for 90 days frozen at -15°C.2801; 2808 Solutions at concentrations of 10 to 250 mg/mL in dextrose 5%; dextrose 5% in sodium chloride 0.45%; sodium lactate 1by6 M; and Ringer's injection, lactated are stated to be stable for 90 days frozen at -15°C.2801; 2808

In one study, however, when nafcillin sodium (Wyeth) 1 g/4 mL was frozen at -20°C in glass syringes (Hy-Pod), the drug was stable for nine months.532

In another study, nafcillin sodium (Wyeth) 1 g/50 mL of dextrose 5% in PVC bags frozen at -20°C for 30 days and then thawed by exposure to ambient temperature or microwave radiation showed no evidence of precipitation or color change but had a 2 to 3% loss. Subsequent storage of the admixture at room temperature for 24 hours also yielded physically compatible solutions with no additional loss of activity.555

Syringes

Nafcillin sodium (Apothecon) 10 mg/mL in sodium chloride 0.9% was packaged in 10-mL polypropylene syringes (Becton Dickinson) and stored at 5 and 25°C. The solutions remained clear under refrigeration for 44 days and at room temperature for seven days. A yellow color developed after 14 days at room temperature. About 2% loss of nafcillin sodium occurred after seven days and 18% loss in 14 days at 25°C. Under refrigeration, 1% loss occurred after 44 days. Stability in glass containers was comparable.2325

Ambulatory Pumps

Nafcillin sodium (Marsam) 20 mg/mL in sterile water for injection in PVC portable pump reservoirs (Pharmacia Deltec) exhibited no loss in three days stored at 25°C and in 14 days at 5°C. However, at a concentration of 120 mg/mL, 6% loss was found in three days at 25°C, and 2% loss occurred in 14 days at 5°C.2080

Nafcillin sodium 40 and 50 mg/mL in sodium chloride 0.9% precipitated in as little as one day at the simulated ambulatory use temperature of 35°C. At 20 mg/mL, precipitation appeared in three days. When stored at room temperature, no precipitation appeared at any concentration in three days.2664

Compatibility

Solution Compatibility

Additive Compatibility

Drugs in Syringe Compatibility

Y-Site Injection Compatibility (1:1 Mixture)

Additional Compatibility Information

Peritoneal Dialysis Solutions

The activity of nafcillin 100 mg/L was evaluated in peritoneal dialysis fluids containing dextrose 1.5 or 4.25% (Dianeal 137, Travenol). Storage at 25°C resulted in no loss of antimicrobial activity in 24 hours.515

The stability of nafcillin sodium (Wyeth) 100 mg/L in peritoneal dialysis solutions (Dianeal 137 and PD2) with heparin sodium 500 units/L was evaluated. About 98% activity remained after 24 hours at 25°C.1228

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions December 5, 2024. © Copyright, 2024. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.